SAN DIEGO, Oct. 23, 2024 /PRNewswire/ — ORFLO Technologies, LLC today announced the official transition of its headquarters to El Cajon California, in the greater San Diego area. Founded in 2010, the company has operated out of its original home in Ketchum Idaho for almost 15 years. As a part of the expansion of United BioChannels (UBC), the relocation of its current subsidiary ORFLO to a centralized location will allow for more synergistic partnerships between ORFLO and other prospective UBC partners.
“We have been very happy with the growth and progress that ORFLO has made after coming under our leadership,” said UBC’s President Jeff Whitmore. “We look forward to the new opportunities on the horizon that the San Diego area will bring to both ORFLO and future endeavors”.
Terry Salyer, CEO of ORFLO, commented “Moving our business to the biotech hub in San Diego is a substantial change, and ORFLO will be able to improve our business with better access to important clients, talented people, and new partnerships. This change will be an invigorating event in the tenure of the company”.
About ORFLO Technologies
ORFLO Technologies, LLC is a life sciences company that develops cell counting and characterization systems for quality control in bioprocessing workflows. The core of ORFLO’s instrumentation includes a patented disposable microfluidic flow cell and achieves the highest accuracy compared to other detection methods. Through the unique combination of electric impedance using Coulter Principle and fluorescence-based flow cytometry detection modes, Orflo’s instruments provide the next generation of cell characterization by measuring fluorescence and cell volume simultaneously and miniaturizes the power of a flow cytometer into a square foot of space. This capability coupled with the simplicity, affordability, and elimination of all fluidics maintenance, enables several advantages over vision systems and has achieved over 3000 instruments sold. For more information please visit https://www.orflo.com/.
SOURCE ORFLO Technologies, LLC
The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…
BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…
CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…
MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…
Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…
MMJ's position is further fortified by its FDA Orphan Drug Designations for the treatment of…